High Growth Tech Stocks To Watch In September 2024

In This Article:

Over the last 7 days, the market has remained flat, but it is up 32% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying high growth tech stocks that can capitalize on these trends is crucial for investors seeking robust returns.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

20.86%

27.98%

★★★★★★

Sarepta Therapeutics

23.58%

44.12%

★★★★★★

TG Therapeutics

28.39%

43.54%

★★★★★★

Invivyd

42.91%

70.39%

★★★★★★

Ardelyx

27.46%

66.34%

★★★★★★

Amicus Therapeutics

20.32%

62.37%

★★★★★★

Clene

71.89%

60.05%

★★★★★★

Travere Therapeutics

26.68%

68.80%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 254 stocks from our US High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Zai Lab

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience, with a market cap of approximately $1.99 billion.

Operations: Zai Lab Limited generates revenue primarily from its biotechnology segment, amounting to $322.71 million. The company's focus spans oncology, autoimmune disorders, infectious diseases, and neuroscience therapies.

Zai Lab, amidst a challenging landscape for unprofitable biotechs, shows promise with its aggressive R&D focus and innovative pipeline. The company's R&D expenses have been substantial, aligning with its strategic priorities in developing treatments like ZL-1503 for atopic dermatitis, showcased at the recent EADV Congress. This focus on novel biologics is crucial as it navigates a 32.8% expected annual revenue growth and a projected leap to profitability within three years. Moreover, Zai Lab's recent approval of efgartigimod SC in China underscores its potential to tap into significant markets, further bolstered by a 65.9% forecasted earnings growth rate annually. This blend of rigorous research investment and strategic market entries encapsulates Zai Lab’s approach to overcoming current unprofitability and positioning itself in the high-stakes biotech arena.

NasdaqGM:ZLAB Earnings and Revenue Growth as at Sep 2024

Sinclair

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sinclair, Inc. (NasdaqGS: SBGI) is a media company that delivers content through local television stations and digital platforms across the United States, with a market cap of approximately $980.17 million.